Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Ivy Riano is a thoracic oncologist at Dartmouth Cancer Center, and Assistant Professor at Dartmouth Cancer Center, affiliated to Geisel School of Medicine at Dartmouth. Her career goal is to become an independent clinician-scientist focused on thoracic malignancies to improve the care of patients with cancer. Her clinical and research interests focused on the development of innovative therapeutic strategies and clinical trials to treat patients with lung cancer through molecularly targeted therapies and immunotherapies.

Program: Patient Education Ambassadors 2023-24
AlexandraGBeneke
The 2023-2024 GRACE Patient Education Ambassadors discuss topics in a variety of cancers, from screening and treating prostate cancer to aiding in the cost of cancer treatment.
Author
Ivy Riano Monsalve, MD - Guest Faculty
Image
Patient Education Ambassadors 2023-24

La Dra. Ivy Riano analiza las diversas opciones de tratamiento para pacientes con cáncer y analiza las diversas opciones de tratamiento para pacientes con cáncer.

Para ver la lista completa de videos da click aquí.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Online Community

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...

The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)

There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...

Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.

The...

Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...

Hi Stan!  So good to hear from you.  I'm sorry for the late response.  I too have been out of town with family and missed your post, probably because I was...

It is so good to hear from you!  And I am so happy to hear that your holidays have been good and that you are doing well.  It sounds like your...

Recent Comments

JOIN THE CONVERSATION
Biomarkers
By JanineT GRACE … on
Radiation Therapy
By JanineT GRACE … on
Oligometastatic vs Oligoprogression
By JanineT GRACE … on
Hi Stan!! and happiest of holidays!
By dbrock on